• 产品
  • 供应商
  • CAS号
  • 采购
  • 资讯
  • 会展活动

您的位置:首页 >> 制药产品大全 >> 原料药 >> Gadolinium spray gluamine injection

Gadolinium spray gluamine injection

Gadolinium spray gluamine injection

更新时间:2023-05-11
CAS号:--
药典:企业标准
级别:药用级
详细描述
  • 主要销售市场:北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
  • 提供样品:
产品描述:

Brief introduction: gadolinium spray gluamine injection (magnetic phloglucamine) produced by Beiriku is the first magnetic resonance contrast agent approved by the Ministry of Health in China.Since its launch at the end of 1992, it has rapidly occupied the market with its excellent product quality and reasonable price, and has been safely applied more than 10 million cases, with good clinical enhancement effect and few side effects.

 

Indications: Used for magnetic resonance imaging of central nervous system (brain and spinal cord), abdomen, chest, pelvic cavity, limbs and other human organs and tissues.

 

Usage and dosage: Intravenous injection, generally 0.2 ml per kg body weight.

 

Adverse reactions: facial flushing, headache, urticaria, nausea, vomiting, bronchospasm, palpitation, dizziness and anaphylactic shock may occur.

 

Contraindications: It is contraindicated for people allergic to this product.

 

Precautions: Use with caution in patients with renal insufficiency.

地址:

城市:

联系人:

电话:

传真:

成为供应商 在线获取商机 申请入驻
快速询盘
原料药
CPHI制药在线为您找到Gadolinium spray gluamine injection价格、Gadolinium spray gluamine injection详细参数、Gadolinium spray gluamine injection相关产品、Gadolinium spray gluamine injection供应商等信息,想了解当前Gadolinium spray gluamine injection最新报价,请联系北京北陆药业股份有限公司
CPHI 网上贸易平台: CPHI.cn| Pharmasources.com| CPHI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00)